Jostein Dahle

Jostein Dahle is an accomplished professional in the fields of research, innovation, and biotechnology, currently serving as the Research and Innovation Leader at Akershus universitetssykehus since February 2024. As the Chief Technology Officer, Chairman of the Board, and Chief Executive Officer at Blue Wave Therapeutics, Jostein Dahle has significant leadership experience. Additionally, as the owner of JOSTEIN DAHLE CONSULTING since April 2023, consulting services focus on areas such as radioimmunotherapy and regulatory affairs. Jostein Dahle's previous roles include Chief Scientific Officer and Chief Executive Officer at Nordic Nanovector ASA, Scientist and group leader at Oslo University Hospital and Norwegian Radium Hospital, as well as early career positions at The Norwegian Radium Hospital. Jostein Dahle holds a PhD in Radiation Biology from the University of Oslo and an MSc in Biophysics from the Norwegian University of Science and Technology, complemented by executive education from prestigious institutions.